The results of the biotechnology pharmaceutical company Teva Baltics were not affected by Israel's war with Iran, but revenue and profits fell due to decisions by Donald Trump, the US President, to reduce drug prices in the country.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The results of the biotechnology pharmaceutical company Teva Baltics were not affected by Israel's war with Iran, but revenue and profits fell due to decisions by Donald Trump, the US President, to reduce drug prices in the country.